Arecoline Alleviates T2DM via Gut Microbiota Modulation and Liver Gene Regulation in Mice
Molecular Nutrition & Food Research · 2025-05 · 69 (9)
DOI: 10.1002/mnfr.70015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, online erschienen am 23.03.2025. Verfasst von Meng Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver, Diabetes Mellitus, Type 2, Arecoline. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Research Fund for the International Science & Technology Cooperation Program of Hainan Province.
Abstract (Originalsprache)
Scope Arecoline, the main alkaloid in areca nut, has shown potential in modulating metabolism and gut microbiota. This study aimed to evaluate its therapeutic effects on glucose and lipid metabolism, inflammation, liver function, and potential mechanisms in a Type 2 diabetes mellitus (T2DM) mouse model. Methods and results T2DM was established in mice with a high‐fat, high‐sugar diet, and streptozotocin injections. Arecoline significantly reduced fasting blood glucose, enhanced glucose tolerance, and increased insulin sensitivity. Serum lipid profiles showed marked decreases in total cholesterol, triglycerides, and LDL‐C levels. Systemic inflammation, as measured by serum levels of IL‐1β, IL‐6, and MCP‐1, decreased significantly. Improvements in liver function were observed, as indicated by reductions in ALT and AST levels. Liver transcriptomic analysis revealed modulation of pathways related to glutathione metabolism, MAPK signaling, and cAMP signaling, which were involved in insulin signaling and oxidative stress response. Additionally, arecoline mitigated gut dysbiosis by restoring microbial diversity, altering gut microbiota composition, and regulating key pathways involved in NAD biosynthesis and fatty acid β‐oxidation, which were critical for maintaining energy homeostasis. Conclusion Arecoline improves glucose metabolism, lipid profiles, and liver function, while modulating gut microbiota and liver metabolic pathways, showing potential as a therapeutic agent for T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food Science and Engineering, Key Laboratory of Food Nutrition and Functional Food of Hainan Province, Hainan University, Haikou, China.
- Collaborative Innovation Center of One Health, Hainan University, Haikou, China.
- Food, Chemical and Biotechnology Cluster, Singapore Institute of Technology, Singapore, Singapore.
- College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
ORCID-Profile: Xiaosong Hu
Förderung
- Research Fund for the International Science & Technology Cooperation Program of Hainan Province
Zitieren
APA
Xu, M., Li, W., Xu, Y., Zhang, J., Xue, H., Du, J., & Hu, X. (2025). Arecoline Alleviates T2DM via Gut Microbiota Modulation and Liver Gene Regulation in Mice. Molecular Nutrition & Food Research, 69(9). https://doi.org/10.1002/mnfr.70015
Vancouver
Xu M, Li W, Xu Y, Zhang J, Xue H, Du J, et al. Arecoline Alleviates T2DM via Gut Microbiota Modulation and Liver Gene Regulation in Mice. Molecular Nutrition & Food Research. 2025;69(9). doi:10.1002/mnfr.70015
BibTeX
@article{Xu2025,
author = {Xu, Meng and Li, Wanggao and Xu, Yuan and Zhang, Jiachao and Xue, Hui and Du, Juan and Hu, Xiaosong},
title = {Arecoline Alleviates T2DM via Gut Microbiota Modulation and Liver Gene Regulation in Mice},
journal = {Molecular Nutrition & Food Research},
year = {2025},
volume = {69},
number = {9},
doi = {10.1002/mnfr.70015}
}
EUVIMED